A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.

Published on Jan 9, 2019in PLOS ONE3.24
路 DOI :10.1371/JOURNAL.PONE.0208118
Hiroshi Yagata17
Estimated H-index: 17
(Saitama Medical University)
Sources
Abstract
Purpose Many breast cancer patients suffer from chemotherapy-induced hair loss. Accurate information about temporal changes in chemotherapy-induced hair loss is important for supporting patients scheduled to receive chemotherapy, because it helps them to prepare. However, accurate information, on issues such as the frequency of hair loss after chemotherapy, when regrowth starts, the condition of regrown hair, and the frequency of incomplete hair regrowth, is lacking. This study aimed to clarify the long-term temporal changes in chemotherapy-induced hair loss using patient-reported outcomes for chemotherapy-induced hair loss. Methods We conducted a multicenter, cross-sectional questionnaire survey. Disease-free patients who had completed adjuvant chemotherapy consisting of anthracycline and/or taxanes for breast cancer within the prior 5 years were enrolled from 47 hospitals and clinics in Japan. Descriptive statistics were obtained in this study. The study is reported according to the STROBE criteria. Results The response rate was 81.5% (1511/1853), yielding 1478 questionnaires. Hair loss occurred in 99.9% of patients. The mean time from chemotherapy until hair loss was 18.0 days. Regrowth of scalp hair occurred in 98% of patients. The mean time from the completion of chemotherapy to the beginning of regrowth was 3.3 months. Two years after chemotherapy completion, the scalp-hair recovery rate was <30% in approximately 4% of patients, and this rate showed no improvement 5 years after chemotherapy. Eighty-four percent of the patients initially used wigs, decreasing to 47% by 1 year after chemotherapy and 15.2% after 2 years. The mean period of wig use was 12.5 months. However, a few patients were still using wigs 5 years after completing chemotherapy. Conclusions Our survey focused on chemotherapy-induced hair loss in breast cancer patients. We believe these results to be useful for patients scheduled to receive chemotherapy.
Figures & Tables
Download
馃摉 Papers frequently viewed together
4 Authors (Nicola Thorp, ..., Helen Wong)
References29
Newest
#2Wang Tao (BCM: Baylor College of Medicine)
Importance Chemotherapy may induce alopecia. Although scalp cooling devices have been used to prevent this alopecia, efficacy has not been assessed in a randomized clinical trial. Objectives To assess whether a scalp cooling device is effective at reducing chemotherapy-induced alopecia and to assess adverse treatment effects. Design, Setting, and Participants Multicenter randomized clinical trial of women with breast cancer undergoing chemotherapy. Patients were enrolled from December 9, 2013, t...
Source
#1Ebenezer Fiifi Emire Atta Mills (DUT: Dalian University of Technology)H-Index: 6
#2Bo Yu (DUT: Dalian University of Technology)H-Index: 13
Last. Lanlan Gu (DUT: Dalian University of Technology)H-Index: 1
view all 3 authors...
This paper deals with a capital to risk asset ratio chance-constrained optimization model in the presence of loans, treasury bill, fixed assets and non-interest earning assets. To model the dynamics of loans, we introduce a modified CreditMetrics approach. This leads to development of a deterministic convex counterpart of capital to risk asset ratio chance constraint. We pursue the scope of analyzing our model under the worst-case scenario i.e. loan default. The theoretical model is analyzed by ...
Source
#1L Rossi (Curie Institute)H-Index: 3
#2D. Stevens (Curie Institute)H-Index: 12
Last. Roman Rouzier (Curie Institute)H-Index: 43
view all 8 authors...
Background The impact of adjuvant chemotherapy on breast cancer prognosis has been demonstrated in randomized trials, but its impact is unknown in real-world populations. The aim of this study was to evaluate the effect of adjuvant chemotherapy on the survival of breast cancer patients in an unselected population. Methods This prospective cohort study included 32,502 women treated at the Institut Curie between 1981 and 2008 for a first invasive breast cancer without metastasis. The patients were...
Source
Background Scalp cooling is a long known method to reduce chemotherapy-induced alopecia in cancer patients with solid tumors. Due to a progress in this method, a medical device enabling individual feedback-controlled temperature regulation was evaluated. Between June 2011 and December 2012, 83 breast cancer patients were included. Evaluation was focussed on the quantification of alopecia, satisfaction and side effects of the scalp cooling system in (neo-) adjuvant chemotherapy regimens. Alopecia...
Source
#1Manon M.C. KomenH-Index: 6
Last. Johan W.R. Nortier (LEI: Leiden University)H-Index: 24
view all 4 authors...
Introduction. The success of scalp cooling in preventing or reducing chemotherapy-induced alopecia (CIA) is highly variable between patients and chemotherapy regimens. The outcome of hair preservation is often unpredictable and depends on various factors.
Source
#1Matti AaproH-Index: 84
#2Hans J. Schmoll (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 15
Last. R. Timothy WebbH-Index: 1
view all 5 authors...
Summary Chemotherapy regimens differ according to the tumor type being treated and are associated with varying degrees of emetogenic potential. Since the distribution of risk factors for chemotherapy-induced nausea and vomiting differs across tumor types, it is important to understand the efficacy of antiemetic regimens in multiple patient populations. To characterize treatment response in patients with various malignancies (e.g., breast, gastrointestinal, genitourinary, and lung) treated with e...
Source
Source
#1Nicolas Kluger (University of Montpellier)H-Index: 18
#2William Jacot (University of Montpellier)H-Index: 31
Last. Didier Bessis (University of Montpellier)H-Index: 31
view all 9 authors...
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/ cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients N. Kluger, W. Jacot, E. Frouin, V. Rigau, S. Poujol, O. Dereure, B. Guillot, G. Romieu & D. Bessis* University of Montpellier 1, Montpellier; Department of Dermatology, Saint-Eloi Hospital, Montpellier; Department of Medical Oncology, CRLC Val d鈥橝urelle, Montpellier; Department of Pathology, Hopital Gui-de-Chauliac, Montpel...
Source
: Hair loss is one of the most common side effects of chemotherapies such as FEC and taxane, and it greatly affects quality of life. We conducted a questionnaire survey of breast cancer patients who were treated with adjuvant chemotherapy about their hair loss. Eighty-five patients participated. They all had lost their hair and suffered from persistent changes in their hair condition, ranging from thinning to curly. More than 80% of patients had worn wigs until their hair had grown back. Further...
#1Im-Ryung Kim (SMC: Samsung Medical Center)H-Index: 10
#2Juhee ChoH-Index: 44
Last. Jung-Hyun YangH-Index: 40
view all 8 authors...
Objectives: Regardless of its negative impact on quality of life, little is known about the importance of alopecia from the patients鈥 perspective. This study aimed to explore the whole experience of chemotherapyinduced alopecia among Korean breast cancer patients including perception, attitudes, preparedness, and changes after alopecia. Methods: Patients expected to experience or had experienced alopecia were recruited at a tertiary hospital in Seoul, Korea. Semi-structured in-depth interviews w...
Source
Cited By8
Newest
#3Pier Paolo Claudio (UMMC: University of Mississippi Medical Center)H-Index: 3
Abstract null null TumorSelect庐 is an anticancer technology that combines cytotoxics, nanotechnology, and knowledge of human physiology to develop innovative therapeutic interventions with minimal undesirable side effects commonly observed in conventional chemotherapy. Tumors have a voracious appetite for cholesterol which facilitates tumor growth and fuels their proliferation. We have transformed this need into a stealth delivery system to disguise and deliver anticancer drugs with the assistan...
Source
#1Qingye Meng (Qingdao University)H-Index: 6
#2Hao Hu (Qingdao University)H-Index: 7
Last. Youqing Shen (ZJU: Zhejiang University)H-Index: 82
view all 9 authors...
Abstract null null Traditional and single treatment strategies are difficult to achieve good results due to tumor resistance and complex mechanisms. Combination therapy through co-delivery systems is one of the methods to improve the effectiveness of cancer treatment. The polyprodrug platform has inherent advantages such as high drug loading and strong stability. Herein, a new reactive oxygen species (ROS)-responsive micelle composed of poly 10-hydroxycamptothecin (pHCPT) and PEG is reported, wh...
Source
#1Run Zhong (GXUN: Guangxi University for Nationalities)
Last. Liu Hongquan (GXUN: Guangxi University for Nationalities)
view all 7 authors...
Abstract Microalgae, one of the most important classes of biomass producers, can produce exopolysaccharides similar to bacteria. The exopolysaccharide from Chlorella (CEPS) displays remarkable anticancer activity the mechanism of which remains to be elucidated. In this study, we analyzed the inhibitory effect of CEPS on the growth of HeLa cells. The results showed that CEPS inhibited the proliferation, decreased the viability, and changed the morphology of HeLa cells. Transcriptome analysis show...
Source
#1N Contessi Negrini (Imperial College London)H-Index: 1
#2Ana Angelova Volponi ('KCL': King's College London)H-Index: 11
Last. Adam D. Celiz (Imperial College London)H-Index: 13
view all 5 authors...
Tissue engineering (TE) is a multidisciplinary research field aiming at the regeneration, restoration, or replacement of damaged tissues and organs. Classical TE approaches combine scaffolds, cells and soluble factors to fabricate constructs mimicking the native tissue to be regenerated. However, to date, limited success in clinical translations has been achieved by classical TE approaches, because of the lack of satisfactory biomorphological and biofunctional features of the obtained constructs...
Source
#1Sudtirak Wongkhieo (Kasetsart University)H-Index: 1
#2Katawut Numdee (Thailand National Science and Technology Development Agency)H-Index: 1
Last. Mattaka Khongkow (Thailand National Science and Technology Development Agency)H-Index: 11
view all 6 authors...
Abstract Forkhead box M1 (FOXM1) is known to play a role in breast cancer progression. FOXM1 inhibition becomes one of the strategies in developing the novel cancer therapy. Recently, thiostrepton has been recognized as a potent FOXM1 inhibitor. To improve its potential, we aimed to develop a nanodelivery system for thiostrepton. Here, liposome-encapsulated thiostrepton (TSLP) was developed. Physiochemical properties were characterized by TEM and dynamic light scattering technique. The biologica...
Source
#1Ilaria Durosini (IEO: European Institute of Oncology)H-Index: 5
#2Lucrezia Savioni (IEO: European Institute of Oncology)H-Index: 6
Last. Gabriella Pravettoni (IEO: European Institute of Oncology)H-Index: 31
view all 5 authors...
Psychological interventions are proposed to cancer survivors to support their quality of life against the emotional trauma of cancer and the side effects of treatment. Psychological interventions often require patient engagement and commitment to activities that could be more or less demanding in terms of lifestyle change (e.g., psychotherapy, sports). Analyzing participant motivations (personal aims, expectations, needs) prior to participation is useful to predict their adherence to the interve...
Source
#1Nao Tamai (UTokyo: University of Tokyo)H-Index: 8
#2Takeo Minematsu (UTokyo: University of Tokyo)H-Index: 15
Last. Hiromi Sanada (UTokyo: University of Tokyo)H-Index: 34
view all 5 authors...
Purpose Chemotherapy causes changes in appearance in patients with cancer. Therefore, to have a normal life, it is necessary for patients to wear a wig. However, wearing a wig may strain an already sensitive scalp during chemotherapy. This study aimed to assess the effects of a hypoallergenic medical wig in breast cancer patients with chemotherapy-induced alopecia (CIA). Methods A randomised, single-blind, controlled study was conducted from January 2015 to July 2017 in Tokyo, Japan. Women with ...
Source
#1Dorit Segal-Engelchin (BGU: Ben-Gurion University of the Negev)H-Index: 10
#2Shifra Shvarts (BGU: Ben-Gurion University of the Negev)H-Index: 11
Hair loss resulting from childhood irradiation for tinea capitis has been linked to mental health effects in women. However, the association of hair loss severity with mental health in this population is unknown. To address this gap, this study examined the association between hair loss severity and mental health outcomes in women irradiated for tinea capitis in childhood as well as the factors that contribute to these outcomes. Medical records, held at the archives of the Israel National Center...
Source
#1Noriko Sagawa (Oita University)H-Index: 4
#2Yusuke Oshima (University of Toyama)H-Index: 2
Last. Masafumi Inomata (Oita University)H-Index: 28
view all 6 authors...
Chemotherapy-induced alopecia is one of the most difficult adverse events of cancer treatment for patients. However, it is still unknown why anticancer drugs cause hair loss. We aimed to clarify the mechanism of chemotherapy-induced alopecia in mice using an in vivo imaging technique with a two-photon microscope, which enables observation of the deep reaction in the living body in real time. In this study, ICR mice were injected intraperitoneally with cyclophosphamide (120 microg/g). Changes in ...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.